Jennifer Castriotta

Array ( [id] => 10960380 [patent_doc_number] => 20140363407 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-12-11 [patent_title] => 'NEURAL STEM CELL THERAPY FOR OBESITY AND DIABETES' [patent_app_type] => utility [patent_app_number] => 14/375582 [patent_app_country] => US [patent_app_date] => 2013-01-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 20210 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14375582 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10919685 [patent_doc_number] => 20140322704 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-10-30 [patent_title] => 'Hepatitis Virus Culture Systems Using Stem Cell-Derived Human Hepatocyte-Like Cells and Their Methods of Use' [patent_app_type] => utility [patent_app_number] => 14/366467 [patent_app_country] => US [patent_app_date] => 2012-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 30 [patent_no_of_words] => 31466 [patent_no_of_claims] => 72 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14366467 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9762082 [patent_doc_number] => 08846402 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-09-30 [patent_title] => 'Method for genetically modifying isolated non-human mammalian cell by homologous recombination' [patent_app_type] => utility [patent_app_number] => 13/719804 [patent_app_country] => US [patent_app_date] => 2012-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 12553 [patent_no_of_claims] => 54 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 215 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13719804 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9582457 [patent_doc_number] => 08772460 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-07-08 [patent_title] => 'Thermostable FGF-2 mutant having enhanced stability' [patent_app_type] => utility [patent_app_number] => 13/717275 [patent_app_country] => US [patent_app_date] => 2012-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 32 [patent_no_of_words] => 9217 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13717275 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8891183 [patent_doc_number] => 20130164367 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-06-27 [patent_title] => 'TREATMENT OF NEURODEGENERATIVE DISEASE WITH CREB-BINDING PROTEIN' [patent_app_type] => utility [patent_app_number] => 13/708444 [patent_app_country] => US [patent_app_date] => 2012-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 25466 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13708444 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9795413 [patent_doc_number] => 20150007357 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-01-01 [patent_title] => 'Use Of Humanized Mice To Determine Toxicity' [patent_app_type] => utility [patent_app_number] => 14/362774 [patent_app_country] => US [patent_app_date] => 2012-12-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 72 [patent_figures_cnt] => 72 [patent_no_of_words] => 12647 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14362774 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8853186 [patent_doc_number] => 20130142861 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-06-06 [patent_title] => 'Compositions And Method For Detecting And Treating Abnormal Liver Homeostasis And Hepatocarcinogenesis' [patent_app_type] => utility [patent_app_number] => 13/689700 [patent_app_country] => US [patent_app_date] => 2012-11-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 28195 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13689700 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10912276 [patent_doc_number] => 20140315294 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-10-23 [patent_title] => 'SCALABLE LENTIVIRAL VECTOR PRODUCTION SYSTEM COMPATIBLE WITH INDUSTRIAL PHARMACEUTICAL APPLICATIONS' [patent_app_type] => utility [patent_app_number] => 14/359960 [patent_app_country] => US [patent_app_date] => 2012-11-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 8157 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14359960 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10938843 [patent_doc_number] => 20140341864 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-11-20 [patent_title] => 'METHODS FOR PRODUCING RETINAL TISSUE AND RETINA-RELATED CELL' [patent_app_type] => utility [patent_app_number] => 14/360534 [patent_app_country] => US [patent_app_date] => 2012-11-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 15950 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14360534 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8916363 [patent_doc_number] => 20130177988 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-07-11 [patent_title] => 'CYTOPLASM TO ORGANELLE DELIVERY SYSTEM AND ASSOCIATED METHODS' [patent_app_type] => utility [patent_app_number] => 13/681260 [patent_app_country] => US [patent_app_date] => 2012-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 11842 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13681260 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8732654 [patent_doc_number] => 20130078223 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-03-28 [patent_title] => 'Method And Composition For Inducing Human Pluripotent Stem Cells' [patent_app_type] => utility [patent_app_number] => 13/677186 [patent_app_country] => US [patent_app_date] => 2012-11-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 7479 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13677186 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9719664 [patent_doc_number] => 20140255363 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-09-11 [patent_title] => 'TARGETING THE TUMOR MICROENVIRONMENT USING MANIPULATED NKT CELLS' [patent_app_type] => utility [patent_app_number] => 14/345394 [patent_app_country] => US [patent_app_date] => 2012-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 48 [patent_figures_cnt] => 48 [patent_no_of_words] => 27257 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14345394 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11237687 [patent_doc_number] => 09464322 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-10-11 [patent_title] => 'Methods for diagnosing and treating alzheimer\'s disease (AD) using the molecules that stabilize intracellular calcium (Ca2+) release' [patent_app_type] => utility [patent_app_number] => 13/608596 [patent_app_country] => US [patent_app_date] => 2012-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 24979 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 124 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13608596 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10945771 [patent_doc_number] => 20140348791 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-11-27 [patent_title] => 'MODIFIED ADENOVIRAL VECTORS AND METHODS OF TREATMENT USING SAME' [patent_app_type] => utility [patent_app_number] => 14/343708 [patent_app_country] => US [patent_app_date] => 2012-09-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 13339 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14343708 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10857896 [patent_doc_number] => 08884097 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2014-11-11 [patent_title] => 'Method to condition an invertebrate to detect a concentration range of a chemical compound' [patent_app_type] => utility [patent_app_number] => 13/590272 [patent_app_country] => US [patent_app_date] => 2012-08-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 5143 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 135 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13590272 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10831348 [patent_doc_number] => 08859517 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-10-14 [patent_title] => 'Method of gene transfer for the treatment of recessive catecholaminergic polymorphic ventricular tachycardia (CPVT)' [patent_app_type] => utility [patent_app_number] => 13/569490 [patent_app_country] => US [patent_app_date] => 2012-08-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 4552 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 88 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13569490 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8732657 [patent_doc_number] => 20130078226 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-03-28 [patent_title] => 'METHOD FOR RECONSTRUCTING IMMUNE FUNCTION USING PLURIPOTENT STEM CELLS' [patent_app_type] => utility [patent_app_number] => 13/565558 [patent_app_country] => US [patent_app_date] => 2012-08-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 61 [patent_figures_cnt] => 61 [patent_no_of_words] => 32794 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13565558 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10062862 [patent_doc_number] => 09101690 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-08-11 [patent_title] => 'Light-activated cation channel and uses thereof' [patent_app_type] => utility [patent_app_number] => 13/555981 [patent_app_country] => US [patent_app_date] => 2012-07-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 34 [patent_no_of_words] => 24983 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13555981 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9016668 [patent_doc_number] => 20130231632 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-09-05 [patent_title] => 'TREATMENT AND PREVENTION OF NEURODEGENERATIVE DISEASES USING GENE THERAPY' [patent_app_type] => utility [patent_app_number] => 13/551495 [patent_app_country] => US [patent_app_date] => 2012-07-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 16903 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13551495 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8768463 [patent_doc_number] => 20130096500 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-04-18 [patent_title] => 'NUCLEIC ACID BASED CARDIOVASCULAR THERAPEUTICS' [patent_app_type] => utility [patent_app_number] => 13/544774 [patent_app_country] => US [patent_app_date] => 2012-07-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20366 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13544774 [rel_patent_id] =>[rel_patent_doc_number] =>)